Diluted EPS came in at $-0.28.
Filings will appear here once submitted to SEC EDGAR.
Common questions about Clearmind Medicine's Q2 2024 earnings report.
Clearmind Medicine (CMND) reported Q2 2024 earnings on June 13, 2024 before market open.
Clearmind Medicine reported diluted EPS of $-0.28 for Q2 2024.